Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)

Recruiting N/A Interventional Study
Transgender Women Aids Hiv
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Male
Study type
Interventional
Purpose
Prevention
Participants needed
110 (estimated)
Sponsor
University of Central Florida · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Aged ≥18 years * Male at birth * Identify as a woman/transgender woman * Should not be consistently using PrEP (less than four doses per week) * Should not have any known allergy or adverse reaction to PrEP or the active drug tenofovir in ART. One of the goals of the study is …
Contacts

Elena Cyrus, PhD

4072661507

elena.cyrus@ucf.edu

CONTACT

Amoy Fraser, PhD, CCRP, PMP

4072668742

amoy.fraser@ucf.edu

CONTACT